Crossref
The FDA’s New Clinical Decision Support Software Guidance and Its Implications for Artificial Intelligence
Utah Law Review · 2026 · 2026 (4)
DOI: 10.63140/z78d.cf0n3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Utah Law Review, 2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). The FDA’s New Clinical Decision Support Software Guidance and Its Implications for Artificial Intelligence. Utah Law Review, 2026(4). https://doi.org/10.63140/z78d.cf0n3
Vancouver
The FDA’s New Clinical Decision Support Software Guidance and Its Implications for Artificial Intelligence. Utah Law Review. 2026;2026(4). doi:10.63140/z78d.cf0n3
BibTeX
@article{euvimed2026,
title = {The FDA’s New Clinical Decision Support Software Guidance and Its Implications for Artificial Intelligence},
journal = {Utah Law Review},
year = {2026},
volume = {2026},
number = {4},
doi = {10.63140/z78d.cf0n3}
}
EUVIMED